Site-selective modification strategies in antibody-drug conjugates (2021)
Attributed to:
Advanced Linker Technology for Antibody-Drug Conjugates
funded by
NERC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1039/d0cs00310g
PubMed Identifier: 33290462
Publication URI: http://europepmc.org/abstract/MED/33290462
Type: Journal Article/Review
Parent Publication: Chemical Society Reviews
Issue: 2
ISSN: 0306-0012